Genomics: risk and outcomes in cardiac surgery

Anesthesiol Clin. 2008 Sep;26(3):399-417. doi: 10.1016/j.anclin.2008.04.002.

Abstract

Coronary artery bypass graft surgery is associated with several frequent postoperative adverse events. Outcome prediction is valued by patients and practitioners, because it provides some measure of balancing risks and benefits and provides expensive or higher-risk therapies to individuals at highest risk. Surgeons and anesthesiologists traditionally have relied on demographic, preoperative, and intraoperative risk factors to predict outcomes after cardiac surgery. Yet, such predictions often have poor positive and negative predictive value for the individual patient. Perioperative genetics attempts to determine the impact of an individual's genetic variation on the risk of developing adverse postoperative outcomes. In this article, the authors discuss emerging evidence that a patient's genetic makeup predisposes him or her to adverse outcomes following cardiac surgery and provide examples from perioperative bleeding, myocardial injury/infarction, and atrial fibrillation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrial Fibrillation / genetics*
  • Blood Platelets / physiology
  • Cardiac Surgical Procedures*
  • Complement Activation / genetics
  • Genetic Variation*
  • Hemorrhage / genetics*
  • Humans
  • Myocardial Infarction / genetics*
  • Outcome Assessment, Health Care
  • Perioperative Care
  • Platelet Membrane Glycoproteins / genetics*
  • Risk Factors

Substances

  • Platelet Membrane Glycoproteins